The Johns Hopkins Wilmer Eye Institute is the largest department of ophthalmology in the United States, and is an internationally-recognized research enterprise. Wilmer receives more funding from the National Eye Institute than any other university system, and is a leading recipient of research funding in the nation.
Wilmer is a thriving place for basic, clinical and translational research. Our researchers are thought leaders in the realm of discovery, dedicated to alleviating human suffering from eye disease by transforming ophthalmic care through innovative research. Our collaboration with multidisciplinary, world-renowned experts in fields such as gene therapy, nanotechnology, and stem cell research, have resulted in groundbreaking discoveries and therapies that enable us to change the way the world sees.
The Center for NanomedicineThe Center for Nanomedicine
is a unique translational nanotechnology enterprise that brings engineers, scientists and clinicians together under one roof on translation of novel drug and gene delivery technologies.
The Center for Stem Cells and Ocular Regenerative MedicineSTORM
is a pioneering, collaborative research effort that integrates expertise across Johns Hopkins to study and eventually cure vision loss and blindness through regenerative medicine.
Wilmer Core Research CentersIn support of creating a highly collaborative, interdisciplinary research environment, Wilmer has several research resource centers known as the Wilmer Core.
Cornea, Cataract and External DiseaseResearch efforts
are aimed at improving the diagnosis, management and treatment of corneal and external disease problems, including cataracts, corneal transplantation, dry eye, contact lenses and excimer laser therapy.
The Dana Center for Preventive OphthalmologyResearch at the Dana Center
focuses on national and international public health prevention of blinding eye disease. Some major studies include: diabetic retinopathy, trachoma, glaucoma, and vision loss and function.
Glaucoma Center of Excellence Research
The vision for the Glaucoma Center of Excellence (GCE) research
is to dramatically improve the outcome for those affected by glaucoma worldwide through the development and implementation of groundbreaking diagnostic and therapeutic methods.
The Neuro-ophthalmology division's research aims
are to: assess the benefit of stem cells in the reversal of visual loss due to optic nerve disease, use various drugs to reduce or prevent visual loss from optic nerve stroke, to prevent thyroid eye disease, and to investigate periocular trauma and optic nerve regeneration.
Ocular Immunology Research
The faculty in the Ocular Immunology division
are focused on the causes of and treatments for ocular inflammatory diseases, such as uveitis, intraocular inflammation, scleritis and iritis.
Ophthalmic Plastic and Reconstructive Research
Researchers in the Ophthalmic Plastic and Reconstructive division
are currently engaged in research related to the eyelids and structures around the eyes in relation to ocular diseases and orbital trauma, and the implications for treatment.
Pediatric Ophthalmology and Adult Strabismus ResearchCurrent research
focuses on detection, management and treatment of pediatric and adult strabismus and amblyopia, as well as clinical technology development and investigative clinical trials.
Retina Research includes retina division faculty-led projects
and multiple laboratories engaged in groundbreaking discoveries aimed at transforming the study and treatment of retinal diseases.
Translational Tissue Engineering Center (TTEC)TTEC
is a joint venture between the Wilmer Eye Institute and the Department of Biomedical Engineering to establish a focus in research, education, and industrial development in the field of regenerative medicine.